Home / Immunoglobulins, Normal Human, for Extravascular Adm. / Czechia
CZ ATC J06BA01 · updated 2 Nov 2026
Immunoglobulins, Normal Human, for Extravascular Adm. shortage in Czechia
Is there an Immunoglobulins, Normal Human, for Extravascular Adm. shortage in Czechia?
Yes. As of 2 Nov 2026, 2 Immunoglobulins, Normal Human, for Extravascular Adm. products are reported short in Czechia, the first since 22 Feb 2023. The company estimate for the return is 31 Dec 2026. Main reason: commercial decision or withdrawal.
Also short in Italy, Austria. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | HIZENTRA 200MG/ML 200MG/ML INJ SOL ISP 1X10ML | CSL Behring GmbH, Marburg | 22 Feb 2023 | 31 Dec 2026 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | HIZENTRA 200MG/ML 200MG/ML INJ SOL ISP 1X20ML | CSL Behring GmbH, Marburg | 22 Feb 2023 | 31 Dec 2026 | Commercial decision or withdrawal Obchodní/marketingové důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.